2023
DOI: 10.1007/s00404-023-06957-2
|View full text |Cite
|
Sign up to set email alerts
|

The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case–control study

Abstract: Purpose: Uterine myomas are the most frequent gynecologic disease. In these cases, myomectomy is performed, traditionally laparotomically. However, alternatives have been widely used, including laparoscopic surgery, endoscopic and robotic surgery. During these techniques the diffuse parenchymatous bleeding remains one of the main intra and postoperative complications and sometime requires unplanned hysterectomies. Recently, hemostatic agents and sealants have been used to prevent excessive blood loss during su… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 40 publications
1
2
0
Order By: Relevance
“…Finally, in our study, there was a significant reduction in LOS, which is one of the main goals of ERAS protocols, along with a reduction in postoperative stress and complication rates, in agreement with the literature [15][16][17][18][19]. This seems to be associated with better pain control by the LRA group compared to the N-LRA, which allows better recovery in the post-operative period.…”
Section: The Tap Block In Minor Gynecologic Surgerysupporting
confidence: 91%
See 1 more Smart Citation
“…Finally, in our study, there was a significant reduction in LOS, which is one of the main goals of ERAS protocols, along with a reduction in postoperative stress and complication rates, in agreement with the literature [15][16][17][18][19]. This seems to be associated with better pain control by the LRA group compared to the N-LRA, which allows better recovery in the post-operative period.…”
Section: The Tap Block In Minor Gynecologic Surgerysupporting
confidence: 91%
“…the patient at 6,12,18,24,36,48, and 72 h after surgery, using the NRS from 0 to 10 in both groups. The amount of drug used for analgesia in the first 48 h after surgery was recorded.…”
mentioning
confidence: 99%
“…Despite the benefits offered by laparoscopy, maintaining hemostasis throughout the procedure can occasionally be challenging. Fortunately, several treatments are available for managing hemostasis during myomectomy, including uterotonics, vasopressin, antifibrinolytic drugs, gelatin-thrombin as a hemostatic sealant, peri-cervical mechanical tourniquet, or laser dissection ( 12 , 13 , 20 , 21 ).…”
Section: Discussionmentioning
confidence: 99%